Terumo Cardiovascular Reports the US FDA’s Approval of CDI OneView Monitoring System


The US FDA has granted 510(k) clearance to the company’s CDI OneView Monitoring System, enabling visualization of various measures at the time of cardiopulmonary bypass surgery to improve perfusion safety and patient outcomes
The system is designed to evaluate ~22 parameters such as measured flow (Q), cardiac index (CI), regional cerebral oxygen saturation (rSO2), oxygen extraction ratio (O2ER), Area Under the DO2 Curve (AUC), and measured arterial oxygen saturation (SaO2)
The system provides configurable and flexible parameter viewing to meet clinical needs while generating critical information for clinicians

Ref: Terumo | Image: Terumo

Related News:- Terumo Blood and Cell Technologies’ Reveos Automated Whole Blood Processing System Receives the US FDA’s Clearance to Boost US Platelet Supply

PharmaShots! Your go-to media platform for customized news ranging for multiple indications. For more information connect with us at connect@pharmashots.com